Viking Global Investors Lp Inhibrx, Inc. (INBX) insider trading activity

VIKING GLOBAL INVESTORS LP Transaction History

Date	Transaction	Value	Shares Traded
May 30 2024	SELL Other acquisition or disposition	$214,524,780 $30.0 p/Share	7,150,826
Aug 28 2023	BUY Open market or private purchase	$9,899,982 $19.35 p/Share	511,627
Oct 07 2022	BUY Open market or private purchase	$39,999,990 $30.0 p/Share	1,333,333
Aug 26 2020	BUY Open market or private purchase	$3,409,743 $18.92 p/Share	180,219
Aug 25 2020	BUY Open market or private purchase	$1,647,220 $19.31 p/Share	85,304
Aug 24 2020	BUY Open market or private purchase	$896,908 $19.43 p/Share	46,161

Also insider at

Wayfair Inc. Consumer Cyclical

> 10% Shareholder

EDIT

Editas Medicine, Inc. Healthcare

> 10% Shareholder

FDC

FIRST DATA CORP

> 10% Shareholder

ABUS

Arbutus Biopharma Corp Healthcare

> 10% Shareholder

MYOV

Myovant Sciences Ltd. Healthcare

> 10% Shareholder

SIOX

Sio Gene Therapies Inc. Healthcare

> 10% Shareholder

UROV

Urovant Sciences Ltd.

> 10% Shareholder

BBIO

BridgeBio Pharma, Inc. Healthcare

ADPT

Adaptive Biotechnologies Corp Healthcare

> 10% Shareholder

DNA

Ginkgo Bioworks Holdings, Inc. Healthcare

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

FDMT

4D Molecular Therapeutics, Inc. Healthcare

RLYB

Rallybio Corp Healthcare

FIGS

FIGS, Inc. Consumer Cyclical

> 10% Shareholder

PRCT

PROCEPT BioRobotics Corp Healthcare

APG

APi Group Corp Industrials

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

RYZB

RayzeBio, Inc.

FLAC

Frazier Lifesciences Acquisition Corp Financial Services

ROIV

Roivant Sciences Ltd. Healthcare

VGI